Lupin gets USFDA’s nod for Emtricitabine and Tenofovir Alafenamide Tablets

19 Dec 2024 Evaluate

Lupin has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Emtricitabine and Tenofovir Alafenamide Tablets, 200 mg/25 mg, to market a generic equivalent of Descovy Tablets, 200 mg/25 mg of Gilead Sciences, Inc. Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivity. This product will be manufactured at Lupin’s Nagpur facility in India.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2162.20 63.50 (3.03%)
19-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.35
Dr. Reddys Lab 1326.00
Cipla 1505.85
Lupin 2162.20
Zydus Lifesciences 985.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.